NCT07058649Not yet recruiting
Downstaging Prediction Model for HCC
Individualized Downstaging Prediction Model for HCC Beyond the UCSF Criteria
Source: ClinicalTrials.gov · Last updated 10 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is a real-world, single-center study that collects imaging and clinical data from patients with HCC who are downstaged beyond the UCSF criteria.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 369 (estimated)
- First submitted
- 1 Jul 2025
- Start date
- 16 Jul 2025
- Primary completion date
- 1 Oct 2027
- Lead sponsor
- Beijing Tsinghua Chang Gung Hospital
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT07058649
What you commit to
- Study type: Observational
- Planned participants: 369
- From 16 Jul 2025 to the primary completion date, 1 Oct 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- (A) Presence of distant metastasis outside the liver; (B) General performance status score (PS score) greater than 2 points.
Who the study is looking for
- (A) Adult patients with HCC over the age of 18 (clinically diagnosed or pathologically diagnosed); (B) Liver function Child-Pugh score of Class A, or Class B with a score of 7 or below (including 7); (C) A single solid tumor with a diameter of ≥6.5 cm; three or more lesions, among which at least one tumor has a diameter \>4.5 cm or the sum of the diameters is ≥8 cm; invasion of major blood vessels regardless of tumor size and number.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.